NuCana (NCNA) Current Taxes (2015 - 2018)
NuCana (NCNA) reported Current Taxes of $2.7 million for Q1 2018, up 1488.75% on a YoY basis from $167230.9 in Q1 2017, and up 609.63% sequentially from $374401.5 in Q4 2017.
NuCana (NCNA) Current Taxes (2015 - 2018) Analysis & Trends
NuCana (NCNA) has 4 years of Current Taxes data on file, last reported at $2.7 million in Q1 2018.
- For the quarter ending Q1 2018, Current Taxes rose 1488.75% year-over-year to $2.7 million; the trailing twelve-month figure through Mar 2018 stood at $2.7 million (up 1488.75% YoY), and the FY2017 full-year result was $363282.2, down 75.7% from the prior year.
- Current Taxes grew to $2.7 million in Q1 2018, from $374401.5 in the prior quarter.
- In the past five years, Current Taxes ranged from a high of $2.7 million in Q1 2018 to a low of $9104.9 in Q4 2015.
- A 4-year average of $915529.9 and a median of $374401.5 in 2017 frame the typical range for Current Taxes.
- Across the five-year window, Current Taxes jumped 14947.11% in 2016 and slumped 72.67% in 2017, its largest moves.
- Tracing NCNA's Current Taxes over 4 years: stood at $9104.9 in 2015, then jumped by 14947.11% to $1.4 million in 2016, then slumped by 72.67% to $374401.5 in 2017, then surged by 609.63% to $2.7 million in 2018.
- Business Quant data shows NCNA's Current Taxes at $2.7 million in Q1 2018, $374401.5 in Q4 2017, and $167230.9 in Q1 2017.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 63.52 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 49.00 Mn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Alnylam Pharmaceuticals | 35.71 Bn | 32.70 Bn | 959.66 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2018 | 2.66 Mn |
| Dec 31, 2017 | 374,401.49 |
| Mar 31, 2017 | 167,230.91 |
| Dec 31, 2016 | 1.37 Mn |
| Dec 31, 2015 | 9,104.94 |